HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >

STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression

Files in This Item:
MCT11-6_1289-1299.pdf1.13 MBPDFView/Open
Supplementary_Figure_Legend.pdfSupplementary Figure Legend92.04 kBPDFView/Open
Supplementary_Figures_1-3.pdfSupplementary Figures 1-3228.09 kBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/52794

Title: STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
Authors: Kohsaka, Shinji Browse this author
Wang, Lei Browse this author
Yachi, Kazuhiro Browse this author
Mahabir, Roshan Browse this author
Narita, Takuhito Browse this author
Itoh, Tamio Browse this author
Tanino, Mishie Browse this author
Kimura, Taichi Browse this author →KAKEN DB
Nishihara, Hiroshi Browse this author →KAKEN DB
Tanaka, Shinya Browse this author →KAKEN DB
Keywords: Brain tumor
GBM
STAT3
temozolomide
MGMT
Issue Date: Jun-2012
Publisher: American Association for Cancer Research
Journal Title: Molecular Cancer Therapeutics
Volume: 11
Issue: 6
Start Page: 1289
End Page: 1299
Publisher DOI: 10.1158/1535-7163.MCT-11-0801
PMID: 22532597
Abstract: Glioblastoma multiforme (GBM) is one of the most aggressive human tumors with a poor prognosis. Current standard treatment includes chemotherapy with the DNA-alkylating agent temozolomide (TMZ) concomitant with surgical resection and/or irradiation. However, a number of cases are resistant to TMZ-induced DNA damage due to elevated expression of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT). Here we show that upregulation of both MGMT and STAT3 was accompanied with acquisition of TMZ resistance in the GBM cell line U87. Inactivation of STAT3 by inhibitor or shRNA downregulated MGMT expression in GBM cell lines. MGMT upregulation was not observed by the treatment of IL-6 which is a strong activator of STAT3. Contrarily, forced expressed MGMT could be downregulated by STAT3 inhibitor which was partially rescued by the proteasome inhibitor, MG132, suggesting the STAT3-mediated posttranscriptional regulation of the protein levels of MGMT. Immunohistochemical analysis of 44 malignant glioma specimens demonstrated significant positive correlation between expression levels of MGMT and phosphorylated STAT3 (pSTAT3) (P < 0.001, r = 0.58). Importantly, the levels of both MGMT and pSTAT3 were increased in the recurrence compared to the primary lesion in paired identical tumors of 12 cases. Finally, we demonstrated that STAT3 inhibitor or STAT3 knockdown potentiated TMZ efficacy in TMZ-resistant GBM cell lines. Therefore, STAT3 inhibitor might be one of the candidate reagents for combination therapy with TMZ for TMZ-resistant GBM patients.
Type: article (author version)
URI: http://hdl.handle.net/2115/52794
Appears in Collections:医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 高阪 真路

Export metadata:

OAI-PMH ( junii2 , jpcoar )

MathJax is now OFF:


 

 - Hokkaido University